|Articles|February 17, 2021
New Cerba Research and Biokortex Partnership
Advertisement
Cerba Research has announced a new partnership with Biokortex to leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity.
The benefits of this new partnership include patients’ biological and medical data from over 25 million patients per year from over 1,000 sites located in Europe, Africa, and North America, a platform for screening and companion diagnostic testing across Europe and Africa, and more.
Click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5